153 related articles for article (PubMed ID: 34286869)
21. Expanding the spectrum of arrhythmogenic cardiomyopathy.
Saffitz JE
J Am Coll Cardiol; 2008 Dec; 52(25):2188-9. PubMed ID: 19095137
[No Abstract] [Full Text] [Related]
22. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
Wu KC
Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy.
Menon SC; Etheridge SP; Liesemer KN; Williams RV; Bardsley T; Heywood MC; Puchalski MD
Pediatr Cardiol; 2014 Oct; 35(7):1279-85. PubMed ID: 24830760
[TBL] [Abstract][Full Text] [Related]
24. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death.
Basso C; Perazzolo Marra M; Rizzo S; De Lazzari M; Giorgi B; Cipriani A; Frigo AC; Rigato I; Migliore F; Pilichou K; Bertaglia E; Cacciavillani L; Bauce B; Corrado D; Thiene G; Iliceto S
Circulation; 2015 Aug; 132(7):556-66. PubMed ID: 26160859
[TBL] [Abstract][Full Text] [Related]
25. Risk stratification for sudden cardiac death after acute myocardial infarction.
Liew R; Chiam PT
Ann Acad Med Singap; 2010 Mar; 39(3):237-46. PubMed ID: 20372761
[TBL] [Abstract][Full Text] [Related]
26. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
[TBL] [Abstract][Full Text] [Related]
27. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
28. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
Groh WJ; Groh MR; Saha C; Kincaid JC; Simmons Z; Ciafaloni E; Pourmand R; Otten RF; Bhakta D; Nair GV; Marashdeh MM; Zipes DP; Pascuzzi RM
N Engl J Med; 2008 Jun; 358(25):2688-97. PubMed ID: 18565861
[TBL] [Abstract][Full Text] [Related]
29. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence.
Medici V; Czlonkowska A; Litwin T; Giulivi C
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439909
[TBL] [Abstract][Full Text] [Related]
31. Phidippides cardiomyopathy: a review and case illustration.
Trivax JE; McCullough PA
Clin Cardiol; 2012 Feb; 35(2):69-73. PubMed ID: 22222888
[TBL] [Abstract][Full Text] [Related]
32. Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.
Patel RK; Mark PB; Halliday C; Steedman T; Dargie HJ; Cobbe SM; Jardine AG
Clin J Am Soc Nephrol; 2011 Mar; 6(3):519-27. PubMed ID: 21088291
[TBL] [Abstract][Full Text] [Related]
33. The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies.
Lamacie MM; Warman-Chardon J; Crean AM; Florian A; Wahbi K
J Neuromuscul Dis; 2019; 6(4):389-399. PubMed ID: 31561382
[TBL] [Abstract][Full Text] [Related]
34. Sudden Cardiac Death in Women.
Haukilahti MAE; Holmström L; Vähätalo J; Kenttä T; Tikkanen J; Pakanen L; Kortelainen ML; Perkiömäki J; Huikuri H; Myerburg RJ; Junttila MJ
Circulation; 2019 Feb; 139(8):1012-1021. PubMed ID: 30779638
[TBL] [Abstract][Full Text] [Related]
35. Analysis of clinical and biochemical spectrum of Wilson disease patients.
Mansoor S; Naveed AK; Majeed A
Indian J Pathol Microbiol; 2012; 55(3):365-9. PubMed ID: 23032833
[TBL] [Abstract][Full Text] [Related]
36. Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management.
Ali-Ahmed F; Dalgaard F; Al-Khatib SM
Am Heart J; 2020 Feb; 220():29-40. PubMed ID: 31765933
[TBL] [Abstract][Full Text] [Related]
37. Arrhythmias and sudden death after dynamic cardiomyoplasty.
Bocchi EA; Moreira LF; de Moraes AV; Bacal F; Sosa E; Stolf NA; Bellotti G; Jatene AD; Pilleggi F
Circulation; 1994 Nov; 90(5 Pt 2):II107-11. PubMed ID: 7955235
[TBL] [Abstract][Full Text] [Related]
38. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function.
Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B
J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842
[TBL] [Abstract][Full Text] [Related]
39. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction.
Dandamudi G; Rampurwala AY; Mahenthiran J; Miller JM; Das MK
Heart Rhythm; 2008 Aug; 5(8):1111-4. PubMed ID: 18675220
[TBL] [Abstract][Full Text] [Related]
40. Role of CMR imaging in risk stratification for sudden cardiac death.
Aljaroudi WA; Flamm SD; Saliba W; Wilkoff BL; Kwon D
JACC Cardiovasc Imaging; 2013 Mar; 6(3):392-406. PubMed ID: 23473115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
